Table 3.
Study | Patient number | Follow-up CT | Change in tu | mor volume | Sensitivity | Specificity | AUC | p | Response criteria |
---|---|---|---|---|---|---|---|---|---|
Responders | Non-responders | ||||||||
Jones et al. (Jones et al., 1999) | 50 | 4-5 w post-Chemo | −11.6% (tumor length) −33.3% (esophageal wall thickness) |
65% | 33% | – | 0.22 | AJCCa | |
van Heijl et al. (van Heijl et al., 2011) | 39 | 14 d during CRT | 12% | 22% | 19% | 92% | 0.63 | 0.18 | Mandardb |
Beer et al. (Beer et al., 2006) | 21 | 14 d during Chemo | −24% | −16% | 100% | 53% | 0.73 | 0.04 | Mandardb |
Griffith et al. (Griffith et al., 1999) | 45 | 6 d (1-17d) post-CRT | ~−55% | ~−35% | – | – | – | 0.58 | Mandardb |
Conventional volume change+ | 20 | 4-6 w post-CRT | −33% | −36% | 64% | 67% | 0.58 | 0.6 | Mandardb |
Jacobian map | −20% | 5% | 94.4% | 91.8% | 0.94 | 0.0002 |
American Joint Committee on Cancer (Edge and Compton, 2010).
Current study.